WHO ICTRP trial
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in…
EUCTR2021-002147-29-IT · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2021-002147-29-IT |
|---|---|
| Public title | A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients with Melanoma (Morpheus-Melanoma) |
| Scientific title | A PHASE Ib/II, OPEN-LABEL, MULTICENTER, RANDOMIZED UMBRELLA STUDY EVALUATING THE EFFICACY AND SAFETY OF MULTIPLE TREATMENT COMBINATIONS IN PATIENTS WITH MELANOMA - MORPHEUS MELANOMA |
| Primary sponsor | F. HOFFMANN - LA ROCHE LTD. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): yes Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | France;Spain;Australia;Netherlands;Italy |
| Conditions | Melanoma MedDRA version: 20.0 Level: HLT Classification code 10027156 Term: Skin melanomas (excl ocular) System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Cancer [C04] |
| Interventions | Trade Name: Tecentriq Product Name: Atezolizumab Product Code: [RO5541267] Pharmaceutical Form: Concentrate for solution for injection/infusion INN or Proposed INN: ATEZOLIZUMAB Current Sponsor code: RO5541267 Concentration unit: mg/ml… |
| Registration date | Jun 9, 2021 |
| Target size | 231 |
| Secondary IDs | BO43328;2021-002147-29-ES |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: